| Literature DB >> 36014946 |
Natalia Yeste1, Jorge Pérez-Valle1, Ana Heras-Molina2, José Luis Pesántez-Pacheco3, Esteban Porrini4, Antonio González-Bulnes5, Anna Bassols1.
Abstract
Intrauterine Growth Restriction (IUGR) hinders the correct growth of the fetus during pregnancy due to the lack of oxygen or nutrients. The developing fetus gives priority to brain development ("brain sparing"), but the risk exists of neurological and cognitive deficits at short or long term. On the other hand, diets rich in fat exert pernicious effects on brain function. Using a pig model of spontaneous IUGR, we have studied the effect on the adult of a long-term high-fat diet (HFD) on the neurotransmitter profile in several brain areas, and the morphology and the proteome of the hippocampus. Our hypothesis was that animals affected by IUGR (born with low birth weight) would present a different susceptibility to an HFD when they become adults, compared with normal birth-weight animals. Our results indicate that HFD affected the serotoninergic pathway, but it did not provoke relevant changes in the morphology of the hippocampus. Finally, the proteomic analysis revealed that, in some instances, NBW and LBW individuals respond to HFD in different ways. In particular, NBW animals presented changes in oxidative phosphorylation and the extracellular matrix, whereas LBW animals presented differences in RNA splicing, anterograde and retrograde transport and the mTOR pathway.Entities:
Keywords: brain; high-fat diet; hippocampus; intrauterine growth restriction; metabolism; neurotransmitters; pig
Mesh:
Substances:
Year: 2022 PMID: 36014946 PMCID: PMC9416793 DOI: 10.3390/nu14163440
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Concentration of neurotransmitters and their metabolites (ng/g tissue) in different brain areas of 1 year-old pigs as a function of diet (Ctrl and HFD), their birth weight (NBW and LBW), and their interaction.
| NT | NBW | LBW | ||||
|---|---|---|---|---|---|---|
| Diet | Weight | Interaction | ||||
| Hippocampus | ||||||
| DOPAC | CTRL | 63.87 ± 4.59 | 74.40 ± 4.13 |
| 0.287 | 0.370 |
| HFD | 81.10 ± 4.79 | 82.01 ± 6.62 | ||||
| HVA | CTRL | 87.12 ± 4.33 | 94.12 ± 5.20 | 0.836 | 0.998 | 0.182 |
| HFD | 93.06 ± 4.47 | 86.04 ± 6.27 | ||||
| DOPtotal | CTRL | 145.90 ± 7.95 | 168.52 ± 8.08 | 0.253 | 0.264 | 0.150 |
| HFD | 168.77 ± 6.30 | 165.85 ± 11.71 | ||||
| 5-HT | CTRL | 336.03 ± 14.03 | 367.69 ± 13.88 |
| 0.371 | 0.551 |
| HFD | 434.76 ± 23.53 | 441.15 ± 25.38 | ||||
| 5-HIAA | CTRL | 191.93 ± 8.13 | 213.85 ± 8.08 | 0.209 | 0.187 | 0.326 |
| HFD | 213.22 ± 7.27 | 216.49 ± 13.56 | ||||
| INDtotal | CTRL | 533.40 ± 18.72 | 581.54 ± 19.35 |
| 0.331 | 0.543 |
| HFD | 655.59 ± 31.81 | 666.77 ± 39.48 | ||||
| Amygdala | ||||||
| DA | CTRL | 705.45 ± 33.80 | 682.81 ± 32.18 | 0.947 | 0.734 | 0.387 |
| HFD | 665.36 ± 39.76 | 717.17 ± 60.81 | ||||
| DOPAC | CTRL | 447.20 ± 41.74 | 543.63 ± 51.70 | 0.828 | 0.150 | 0.447 |
| HFD | 470.87 ± 36.03 | 501.09 ± 43.99 | ||||
| HVA | CTRL | 814.35 ± 19.52 | 861.67 ± 63.50 | 0.285 | 0.809 | 0.543 |
| HFD | 908.06 ± 52.11 | 887.69 ± 71.62 | ||||
| DOPtotal | CTRL | 1966.99 ± 68.37 | 2088.12 ± 121.17 | 0.928 | 0.343 | 0.862 |
| HFD | 1995.30 ± 90.14 | 2079.17 ± 143.26 | ||||
| 5-HT | CTRL | 1501.57 ± 95.32 | 1567.02 ± 99.18 |
| 0.171 | 0.482 |
| HFD | 1685.72 ± 80.52 | 1886.99 ± 107.41 | ||||
| 5-HIAA | CTRL | 618.86 ± 27.66 | 678.11 ± 27.91 | 0.575 | 0.082 | 0.786 |
| HFD | 643.03 ± 20.20 | 686.51 ± 38.39 | ||||
| INDtotal | CTRL | 2120.43 ± 100.44 | 2245.12 ± 102.41 |
| 0.061 | 0.452 |
| HFD | 2315.06 ± 89.82 | 2601.64 ± 129.96 | ||||
| Prefrontal cortex | ||||||
| DOPAC | CTRL | 71.95 ± 8.07 | 70.87 ± 5.75 | 0.818 | 0.910 | 0.945 |
| HFD | 70.17 ± 4.05 | 69.91 ± 6.01 | ||||
| HVA | CTRL | 150.58 ± 5.95 | 158.25 ± 6.52 | 0.307 | 0.697 | 0.386 |
| HFD | 149.63 ± 5.82 | 146.70 ± 5.50 | ||||
| DOPtotal | CTRL | 222.53 ± 7.88 | 229.12 ± 9.81 | 0.361 | 0.838 | 0.557 |
| HFD | 219.80 ± 8.40 | 216.60 ± 6.40 | ||||
| 5-HT | CTRL | 325.93 ± 13.14 | 362.59 ± 26.87 |
| 0.189 | 0.740 |
| HFD | 378.39 ± 17.81 | 400.40 ± 26.18 | ||||
| 5-HIAA | CTRL | 163.75 ± 9.58 | 170.88 ± 9.90 | 0.385 | 0.326 | 0.884 |
| HFD | 169.89 ± 3.98 | 179.48 ± 9.77 | ||||
| INDtotal | CTRL | 489.68 ± 21.47 | 533.47 ± 34.18 | 0.073 | 0.193 | 0.832 |
| HFD | 548.29 ± 20.52 | 579.88 ± 34.62 | ||||
| Hypothalamus | ||||||
| DA | CTRL | 361.95 ± 30.94 | 348.53 ± 27.16 |
| 0.569 | 0.905 |
| HFD | 428.97 ± 20.97 | 408.44 ± 31.99 | ||||
| L-DOPA | CTRL | 652.69 ± 54.48 | 600.27 ± 104.22 | 0.13 | 0.212 | 0.653 |
| HFD | 781.39 ± 51.58 | 670.69 ± 55.58 | ||||
| DOPAC | CTRL | 511.69 ± 28.01 | 585.81 ± 60.98 | 0.817 | 0.813 | 0.163 |
| HFD | 564.78 ± 51.55 | 511.92 ± 24.00 | ||||
| HVA | CTRL | 616.73 ± 57.76 | 606.47 ± 50.58 | 0.876 | 0.715 | 0.876 |
| HFD | 616.73 ± 39.71 | 591.17 ± 38.61 | ||||
| DOPtotal | CTRL | 2225.07 ± 143.97 | 2057.62 ± 255.38 | 0.293 | 0.176 | 0.878 |
| HFD | 2391.87 ± 91.40 | 2182.21 ± 98.13 | ||||
| 5-HT | CTRL | 1250.61 ± 78.97 | 1146.07 ± 151.71 |
| 0.732 | 0.180 |
| HFD | 1352.55 ± 88.09 | 1527.81 ± 97.94 | ||||
| 5-HIAA | CTRL | 645.40 ± 37.09 | 622.28 ± 48.06 | 0.297 | 0.943 | 0.601 |
| HFD | 665.78 ± 35.64 | 683.32 ± 29.96 | ||||
| INDtotal | CTRL | 1907.75 ± 100.41 | 1768.35 ± 162.49 |
| 0.832 | 0.191 |
| HFD | 2018.33 ± 110.94 | 2211.14 ± 120.42 | ||||
| Striatum | ||||||
| DA | CTRL | 21,834.51 ± 2607.80 | 25,637.38 ± 2479.18 | 0.373 |
| 0.280 |
| HFD | 21,412.39 ± 1348.85 | 29,970.72 ± 2353.49 | ||||
| L-DOPA | CTRL | 2275.64 ± 248.13 | 1962.68 ± 242.11 | 0.528 | 0.061 | 0.636 |
| HFD | 2516.53 ± 221.93 | 1997.44 ± 122.63 | ||||
| DOPAC | CTRL | 4260.22 ± 217.81 | 4320.28 ± 189.50 |
| 0.437 | 0.653 |
| HFD | 3693.90 ± 116.83 | 3918.48 ± 201.54 | ||||
| HVA | CTRL | 11,262.32 ± 795.05 | 12,643.72 ± 689.32 | 0.175 | 0.113 | 0.655 |
| HFD | 10,641.91 ± 602.61 | 11,422.03 ± 578.05 | ||||
| 3-MT | CTRL | 1210.46 ± 96.21 | 1472.53 ± 56.29 | 0.151 |
| 0.272 |
| HFD | 1181.48 ± 71.50 | 1259.28 ± 89.19 | ||||
| DOPtotal | CTRL | 38,533.33 ± 1575.54 | 46,228.27 ± 2016.19 | 0.721 |
| 0.401 |
| HFD | 39,446.20 ± 1443.33 | 43,976.56 ± 2328.97 | ||||
| 5-HT | CTRL | 705.05 ± 29.61 | 720.23 ± 23.70 |
| 0.119 | 0.309 |
| HFD | 740.54 ± 24.01 | 811.32 ± 29.54 | ||||
| 5-HIAA | CTRL | 533.18 ± 33.11 | 540.28 ± 29.01 | 0.230 | 0.459 | 0.629 |
| HFD | 553.12 ± 23.37 | 586.66 ± 22.67 | ||||
| INDtotal | CTRL | 1270.54 ± 50.59 | 1260.51 ± 45.79 | 0.057 | 0.239 | 0.161 |
| HFD | 1293.66 ± 31.07 | 1406.73 ± 46.71 | ||||
Concentrations are presented as the mean ± SE. The columns show the neurotransmitters and metabolites in function of birth weight (LBW or NBW). The rows divide pigs in function of diet (Ctrl of HFD). p-values in bold indicate significant differences. DA: Dopamine; DOPAC: 3,4-dihydroxyphenyl acetic acid; HVA: Homovanillic acid; 3-MT: 3-Methoxytyramine; 5-HT: Serotonin/5-Hydroxytryptamine; 5-HIAA: 5-Hydroxyindoleacetic acid; DOP total: Total dopaminergic neurotransmitters; IND total: Total serotoninergic neurotransmitters. Statistical significance was determined by UNIANOVA with Tukey adjustment.
Effect of HFD on NeuN immunostaining in the hippocampus of one year-old pigs born with normal birth weight (NBW) or low birth weight as result of IUGR (LBW) and fed a control diet (Ctrl) or an HFD diet.
| NBW | LBW | ||||||
|---|---|---|---|---|---|---|---|
| Diet | Weight | Interaction | |||||
|
|
|
|
| 481.00 ± 161.83 | 0.897 |
| 0.539 |
|
| 336.84 ± 12.63 | 505.50 ± 22.00 | |||||
|
|
| 650.90 ± 52.89 | 626.75 ± 145.43 | 0.521 | 0.175 | 0.309 | |
|
| 767.67 ± 30.49 | 600.20 ± 34.96 | |||||
|
|
| 12.60 ± 0.61 | 15.00 ± 1.94 |
|
| 0.759 | |
|
| 14.45 ± 0.46 | 17.47 ± 0.98 | |||||
|
|
|
| 208.56 ± 10.39 | 217.33 ± 15.34 | 0.084 | 0.333 | 0.825 |
|
| 226.42 ± 4.74 | 240.38 ± 5.55 | |||||
|
|
| 1345.26 ± 45.64 | 1131.78 ± 164.07 | 0.575 | 0.050 | 0.260 | |
|
| 1307.23 ± 29.95 | 1244.58 ± 26.85 | |||||
|
|
| 15.92 ± 0.55 | 13.96 ± 1.20 |
| 0.322 | 0.180 | |
|
| 17.02 ± 0.39 | 17.32 ± 0.48 | |||||
|
|
| 92.44 ± 2.36 | 92.72 ± 3.29 |
| 0.781 | 0.857 | |
|
| 84.08 ± 1.75 | 85.39 ± 4.57 | |||||
Results are presented as (mean ± SE). In the main effects, significant differences are marked in bold. ImageJ was used for quantification.
Figure 1NeuN immunostaining on the hippocampus of one year-old pigs born with normal birth weight (NBW) or low birth weight as result of IUGR (LBW) and fed a control diet (Ctrl, A,B) or an HFD diet (C,D). Representative images show the mature neurons immunostained with the NeuN antibody. Panels are magnifications of the CA1 (a1–d1) and DG (a2–d2) areas shown using black boxes. Scale bars: 1000 µm (A–D), and 250 µm (a1–d1, a2–d2).
Figure 2DCX immunostaining on the DG of the hippocampus of one year-old pigs born with normal birth weight (NBW, (A)) or low birth weight as result of IUGR (LBW, (B)) and fed a control diet (Ctrl) or an HFD diet (identified as 1 or 2, respectively). Representative images show the immature neurons immunostained with the DCX antibody. Scale bars: 250 µm.
Figure 3Venn diagram of differentially abundant proteins in the hippocampus of pigs. (A) Number of proteins identified by birth weight, diet and its interaction (Birthweight*Diet). (B) Number of proteins identified by comparing HFD vs. Ctrl in NBW and LBW groups.
Figure 4Heatmap of differentially abundant proteins in the hippocampus of pigs in the four analyzed groups (NBW subjected to a control diet (C) or HFD; LBW subjected to a control diet (C) or HFD). Sex of the individual (M, F) is indicated. Numbers indicate the TMT labeling reagent and F indicates the TMT labeling reaction.
Figure 5Functional classification of differentially abundant proteins identified in pigs comparing the effect of an HFD diet in NBW and LBW animals by Slim-GO analysis of the Molecular function and biological processes ontologies. (left hand) Molecular Function: A, binding; B, catalytic activity; C, molecular adaptor activity; D: molecular function regulator; E, molecular transducer activity; F: structural molecule activity; G, transporter activity. (right hand) Biological Process: A, biological regulation; B, cellular processes; C, developmental process; D, localization; E, locomotion; F, metabolic process; G, multicellular organismal process; H, response to stimuli; I, signaling; J, biological adhesion; K, growth.
Response of NBW and LBW animals to an HFD. Comparison between GO categories in NBW and LBW groups: Main categories from Panther have been selected and fold of enrichment indicated. Only main categories with the highest enrichment fold are shown.
| NBW | Enrichment | LBW | Enrichment |
|---|---|---|---|
| Biological Process | |||
| negative regulation of synaptic vesicle exocytosis (GO:2000301) | 69.81 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 24.25 |
| oxidative phosphorylation (GO:0006119) | 7.21 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 16.01 |
| ATP metabolic process (GO:0046034) | 5.18 | post-Golgi vesicle-mediated transport (GO:0006892) | 9.90 |
| regulation of vesicle-mediated transport (GO:0060627) | 3.96 | ||
| Molecular Function | |||
| cadherin binding (GO:0045296) | 3.96 | pre-mRNA binding (GO:0036002) | 16.42 |
| cytoskeletal protein binding (GO:0008092) | 2.90 | structural constituent of cytoskeleton (GO:0005200) | 7.18 |
| oxidoreductase activity (GO:0016491) | 2.82 | cadherin binding (GO:0045296) | 4.96 |
| RNA binding (GO:0003723) | 2.07 | actin binding (GO:0003779) | 4.48 |
| Cellular Component | |||
| platelet alpha granule membrane (GO:0031092) | 20.53 | UFD1-NPL4 complex (GO:0036501) | >100 |
| cytochrome complex (GO:0070069) | 11.35 | endoplasmic reticulum-Golgi intermediate compartment membrane (GO:0033116) | 6.93 |
| lysosomal lumen (GO:0043202) | 7.20 | ruffle membrane (GO:0032587) | 6.47 |
| basement membrane (GO:0005604) | 7.20 | exocytic vesicle (GO:0070382) | 4.66 |
| lipid droplet (GO:0005811) | 7.20 | postsynaptic density (GO:0014069) | 4.46 |
| Schaffer collateral-CA1 synapse (GO:0098685) | 7.01 | asymmetric synapse (GO:0032279) | 4.39 |
| respiratory chain complex (GO:0098803) | 6.54 | postsynaptic specialization (GO:0099572) | 4.14 |
| glutamatergic synapse (GO:0098978) | 5.32 | ||
| secretory granule membrane (GO:0030667) | 3.74 | ||
| secretory granule lumen (GO:0034774) | 3.62 |
List of the most representative differential proteins involved in the response of NBW and LBW pigs to an HFD identified by KEGG pathway analysis.
| Pathways | n | Proteins | |
|---|---|---|---|
| NBW | Metabolic pathways | 25 | COQ7; ATP5PD; CKMT2; COX6B1; COX7A2; COX15; STT3B; AK2; ALDH1A3; PLCH1; GLUD2; GNS; GSTP1; APRT; ARSA; ND1; MVD; NDUFS5; ACOX1; PKM; UQCRC2; CA4; DGKE; AGPS; KYAT1 |
| Thermogenesis | 10 | ATP5PD; COX6B1; COX7A2; COX15; ND1; NDUFS5; COA1; MAP2K3; RHEB; UQCRC2 | |
| Oxidative phosphorylation | 7 | ATP5PD; COX6B1; COX7A2; COX15; ND1; NDUFS5; UQCRC2 | |
| Autophagy | 7 | AKT2; ATG4B; ITPR1; LAMP2; ZFYVE1; RHEB; ATG3 | |
| Focal adhesion and ECM–receptor interaction | 7 | COL4A1; AKT2; PARVB; ITGA7; PPP1CA; RAP1B; BRAF; HSPG2; AGRIN | |
| Insulin signaling pathway | 6 | AKT2; PPP1CA; PRKAR1B; PTPRF; RHEB; BRAF | |
| cAMP signaling pathway | 6 | AKT2; ATP2A1; ACOX1; PPP1CA; RAP1B; BRAF | |
| Lysosome | 5 | NPC2; GNS; LAMP2; ARSA; AP3B1 | |
| MAPK signaling pathway | 5 | AKT2; NF1; MAP2K3; RAP1B; BRAF | |
| Protein processing in the ER | 4 | SEC63; STT3B; NPLOC4; PDIA4 | |
| LBW | Metabolic pathways | 30 | CBS; CDIPT; PAICS; DGKB; FASN; PLCH1; SIRT5; TKFC; GCSH; GFPT1; ACAD8; MAT2B; GMPPA; HADHA; ARSB; ND1; NDUFS5; ALDH7A1; PDE4B; COQ3; PIK3C3; PMM1; CYCS; UCKL1; PPT1; ECHDC1; CHPT1; CBR1; KYAT1; PIGS |
| Thermogenesis | 7 | ND1; NDUFS5; COA1; RPTOR; RHEB; RPS6KA3; SMARCC1 | |
| Spliceosome | 7 | U2AF2; DDX5; HNRNPK; SRSF4; SRSF6; TRA2B; RBM8A | |
| Autophagy | 6 | PIK3R4; PIK3C3; MAPK10; RPTOR; RHEB; DEPTOR | |
| Protein processing in endoplasmic reticulum | 6 | SEC61B; DNAJB2; NPLOC4; MAPK10; SEC62; UFD1 | |
| cAMP signaling pathway | 5 | GRIA4; AFDN; ATP2A1; PDE4B; MAPK10 | |
| Lysosome | 5 | AP3S1; FUCA1; ARSB; PPT1; SORT1 | |
| mTOR signaling pathway | 4 | RPTOR; RHEB; RPS6KA3; DEPTOR | |
| Focal adhesion | 4 | DIAPH1; ITGB8; PARVA; MAPK10 | |
| Insulin signaling pathway | 4 | FASN; MAPK10; RPTOR; RHEB |
Figure 6Voronoi diagram sections obtained with Reactome showing the main pathways regulated by an HFD in NBW and LBW groups. Intensity of yellow color indicates abundance of DAPs in a specific pathway. The complete Voronoi picture and images with enlarged letter size is shown in Supplementary Figure S1.
Differentially abundant proteins identified in NBW and LBW animals subjected to Ctrl and HFD diets. In red: Upregulated in HFD versus Ctrl. In Green: Down-Regulated in HFD versus Ctrl.
| Access UniProt | Gene | Identification | |
|---|---|---|---|
| NBW | Oxidative phosphorylation/Respiratory chain | ||
| F1RPD2 |
| Cytochrome b-c1 complex subunit 2, mitochondrial | |
| F1S8W1 |
| Cytochrome c oxidase assembly protein COX15 homolog isoform 1 | |
| F1S4V0 |
| Cytochrome c oxidase subunit 7A2, mitochondrial | |
| I3LR62 |
| Cytochrome c oxidase assembly factor 1 homolog | |
| F1SV23 |
| Complex I-15 kDa | |
| O79874 |
| NADH-ubiquinone oxidoreductase chain 1 | |
| A0A5G2QL31 |
| Cytochrome c oxidase subunit 6B1 | |
| F1SMF9 |
| ATP synthase subunit d, mitochondrial | |
| Focal adhesion and ECM–receptor interaction | |||
| I3LGD9 |
| Agrin | |
| F1SJU4 |
| Parvin beta | |
| A0A481B0D0 |
| Integrin alpha-2 | |
| M3V819 |
| Collagen alpha-1 (IV) chain isoform 1 preproprotein | |
| F1RW32 |
| SPARC like 1 | |
| F1SU03 |
| Heparan sulfate proteoglycan 2 | |
| LBW | mRNA splicing | ||
| I3LFJ5 |
| SURP and G-patch domain containing 2 | |
| F1S6R7 |
| Polypyrimidine tract-binding protein 1 | |
| F1RZV6 |
| KH RNA binding domain containing, signal transduction associated 2 | |
| P80230 |
| Enhancer of rudimentary homolog | |
| Q06AA7 |
| Transformer 2 beta homolog | |
| I3LDY1 |
| Echinoderm microtubule-associated protein-like 1 | |
| F6QB00 |
| Serine/arginine-rich splicing factor 4 isoform X1 | |
| I3W8V7 |
| Splicing factor U2AF 65 kDa subunit | |
| I3LI59 |
| RNA-binding protein 8A | |
| A0A286ZM27 |
| DEAD box protein 5 | |
| I3LQS0 |
| Heterogeneous nuclear ribonucleoprotein K | |
| K7GNF4 |
| Synaptic functional regulator FMR1 | |
| F1RUN0 |
| CUGBP Elav-like family member 2 | |
| A0A4X1TTZ9 |
| Serine/arginine-rich splicing factor 6 | |
| K7GNY3 |
| KH domain-containing, RNA-binding, signal transduction-associated protein 3 | |
| mTOR signaling pathway | |||
| Q5D891 |
| Phosphatidylinositol 3-kinase catalytic subunit type 3 | |
| K9IWD2 |
| Phosphoinositide 3-kinase regulatory subunit 4 | |
| A0A480DP04 |
| DEP domain-containing mTOR-interacting protein | |
| I3L942 |
| Regulatory associated protein of MTOR complex 1 | |
| F1SQN4 |
| Ribosomal protein S6 kinase alpha-3 | |
| F2Z5R2 |
| GTP-binding protein Rheb | |
Figure 7KEGG diagram for the mTOR pathway (hsa04150) with the differentially abundant proteins identified in LBW animals subjected to an HFD marked by red squares.